MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

09 Aug 2024 Evaluate
The Sales for the quarter ended June 2024 of Rs. 41602.00 millions rose by 40.75% from Rs. 29557.00 millions.The company almost doubled its revenue to Rs. 17008.00 millions  from Rs. 7809.00 millions in the quarter ended June 2024.The company reported a good operating profit of 24795.00 millions compared to 12234.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 41602.00 29557.00 40.75 41602.00 29557.00 40.75 108187.00 87316.00 23.90
Other Income 1066.00 824.00 29.37 1066.00 824.00 29.37 11595.00 8219.00 41.08
PBIDT 24795.00 12234.00 102.67 24795.00 12234.00 102.67 51435.00 30028.00 71.29
Interest 1154.00 897.00 28.65 1154.00 897.00 28.65 3907.00 2782.00 40.44
PBDT 23641.00 11337.00 108.53 23641.00 11337.00 108.53 47442.00 25208.00 88.20
Depreciation 1306.00 1212.00 7.76 1306.00 1212.00 7.76 5044.00 4886.00 3.23
PBT 22335.00 10125.00 120.59 22335.00 10125.00 120.59 42398.00 20322.00 108.63
TAX 5327.00 2316.00 130.01 5327.00 2316.00 130.01 7983.00 5030.00 58.71
Deferred Tax 11.00 -48.00 -122.92 11.00 -48.00 -122.92 -1360.00 412.00 -430.10
PAT 17008.00 7809.00 117.80 17008.00 7809.00 117.80 34415.00 15292.00 125.05
Equity 1006.00 1012.00 -0.59 1006.00 1012.00 -0.59 1006.00 1012.00 -0.59
PBIDTM(%) 59.60 41.39 43.99 59.60 41.39 43.99 47.54 34.39 38.25
Peers
Company Name CMP
Sun Pharma. Inds. 1745.50
Dr. Reddys Labs. 1233.00
Cipla 1330.80
Lupin 1950.00
Zydus Lifesciences 1117.30
View more..